Page last updated: 2024-10-31

metyrapone and Delirium of Mixed Origin

metyrapone has been researched along with Delirium of Mixed Origin in 2 studies

Metyrapone: An inhibitor of the enzyme STEROID 11-BETA-MONOOXYGENASE. It is used as a test of the feedback hypothalamic-pituitary mechanism in the diagnosis of CUSHING SYNDROME.
metyrapone : An aromatic ketone that is 3,3-dimethylbutan-2-one in which the methyl groups at positions 1 and 4 are replaced by pyridin-3-yl groups. A steroid 11beta-monooxygenase (EC 1.14.15.4) inhibitor, it is used in the diagnosis of adrenal insufficiency.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kawashima, T1
Oda, M1
Kuno, T1
Ueki, H1
Yamada, S1
Hisatomi, A1
Kramlinger, KG1
Peterson, GC1
Watson, PK1
Leonard, LL1

Other Studies

2 other studies available for metyrapone and Delirium of Mixed Origin

ArticleYear
Metyrapone for delirium due to Cushing's syndrome induced by occult ectopic adrenocorticotropic hormone secretion.
    The Journal of clinical psychiatry, 2004, Volume: 65, Issue:7

    Topics: ACTH Syndrome, Ectopic; Adrenocorticotropic Hormone; Cushing Syndrome; Delirium; Enzyme Inhibitors;

2004
Metyrapone for depression and delirium secondary to Cushing's syndrome.
    Psychosomatics, 1985, Volume: 26, Issue:1

    Topics: Cushing Syndrome; Delirium; Depressive Disorder; Humans; Male; Metyrapone; Middle Aged

1985